JPMorgan Chase initiated coverage on shares of Healthequity (NASDAQ:HQY) in a research report issued to clients and investors on Tuesday. The firm set a “buy” rating and a $69.00 price target on the stock. JPMorgan Chase’s price objective would indicate a potential upside of 4.04% from the stock’s current price. A number of other brokerages […]